BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 31179514)

  • 1. Cost Effectiveness of Advanced Pharmacy Services Provided in the Community and Primary Care Settings: A Systematic Review.
    Dawoud DM; Haines A; Wonderling D; Ashe J; Hill J; Varia M; Dyer P; Bion J
    Pharmacoeconomics; 2019 Oct; 37(10):1241-1260. PubMed ID: 31179514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness and cost effectiveness of pharmacist input at the ward level: a systematic review and meta-analysis.
    Dawoud DM; Smyth M; Ashe J; Strong T; Wonderling D; Hill J; Varia M; Dyer P; Bion J
    Res Social Adm Pharm; 2019 Oct; 15(10):1212-1222. PubMed ID: 30389320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic evaluations of clinical pharmacy services: 2006-2010.
    Touchette DR; Doloresco F; Suda KJ; Perez A; Turner S; Jalundhwala Y; Tangonan MC; Hoffman JM
    Pharmacotherapy; 2014 Aug; 34(8):771-93. PubMed ID: 24644086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic Evaluation of Hospital and Community Pharmacy Services.
    Gammie T; Vogler S; Babar ZU
    Ann Pharmacother; 2017 Jan; 51(1):54-65. PubMed ID: 27586430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic Review of Economic Evaluations of Services Provided by Community Pharmacists.
    Sanyal C; Husereau D
    Appl Health Econ Health Policy; 2020 Jun; 18(3):375-392. PubMed ID: 31755015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of professional pharmacy services in community pharmacy: a systematic review.
    Malet-Larrea A; García-Cárdenas V; Sáez-Benito L; Benrimoj SI; Calvo B; Goyenechea E
    Expert Rev Pharmacoecon Outcomes Res; 2016 Dec; 16(6):747-758. PubMed ID: 27828725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigating influences on current community pharmacy practice at micro, meso, and macro levels.
    Hermansyah A; Sainsbury E; Krass I
    Res Social Adm Pharm; 2017; 13(4):727-737. PubMed ID: 27530306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Home treatment for mental health problems: a systematic review.
    Burns T; Knapp M; Catty J; Healey A; Henderson J; Watt H; Wright C
    Health Technol Assess; 2001; 5(15):1-139. PubMed ID: 11532236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacist's Demand for Optimal Primary Care Service Delivery in a Community Pharmacy: The OPTiPharm Study.
    Munger MA; Walsh M; Godin J; Feehan M
    Ann Pharmacother; 2017 Dec; 51(12):1069-1076. PubMed ID: 28737045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solidarity or dissonance? A systematic review of pharmacist and GP views on community pharmacy services in the UK.
    Hindi AMK; Jacobs S; Schafheutle EI
    Health Soc Care Community; 2019 May; 27(3):565-598. PubMed ID: 30047617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How has the impact of 'care pathway technologies' on service integration in stroke care been measured and what is the strength of the evidence to support their effectiveness in this respect?
    Allen D; Rixson L
    Int J Evid Based Healthc; 2008 Mar; 6(1):78-110. PubMed ID: 21631815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic evaluation of pharmacy services: a systematic review of the literature (2016-2020).
    Phimarn W; Saramunee K; Leelathanalerk A; Srimongkon P; Chanasopon S; Phumart P; Paktipat P; Babar ZU
    Int J Clin Pharm; 2023 Dec; 45(6):1326-1348. PubMed ID: 37233864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of the clinical and economic outcomes of pharmacy interventions in drug-related problems.
    Westerlund T; Marklund B
    J Clin Pharm Ther; 2009 Jun; 34(3):319-27. PubMed ID: 19646078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-utility analysis of offering a novel remunerated community pharmacist consultation service on influenza vaccination for seniors in Ontario, Canada.
    Pullagura GR; Waite NM; Houle SKD; Violette R; Wong WWL
    J Am Pharm Assoc (2003); 2019; 59(4):489-497.e1. PubMed ID: 30979576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The I-Tribe Community Pharmacy Practice Model: professional pharmacy unshackled.
    Alston GL; Waitzman JA
    J Am Pharm Assoc (2003); 2013; 53(2):163-71. PubMed ID: 23571624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The BC Community Pharmacy Asthma Study: A study of clinical, economic and holistic outcomes influenced by an asthma care protocol provided by specially trained community pharmacists in British Columbia.
    McLean W; Gillis J; Waller R
    Can Respir J; 2003; 10(4):195-202. PubMed ID: 12851665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost analysis for the implementation of a medication review with follow-up service in Spain.
    Noain A; Garcia-Cardenas V; Gastelurrutia MA; Malet-Larrea A; Martinez-Martinez F; Sabater-Hernandez D; Benrimoj SI
    Int J Clin Pharm; 2017 Aug; 39(4):750-758. PubMed ID: 28434119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors influencing national implementation of innovations within community pharmacy: a systematic review applying the Consolidated Framework for Implementation Research.
    Weir NM; Newham R; Dunlop E; Bennie M
    Implement Sci; 2019 Mar; 14(1):21. PubMed ID: 30832698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Community Pharmacists Assisting in Total Cardiovascular Health (CPATCH): A Cluster-Randomized, Controlled Trial Testing a Focused Adherence Strategy Involving Community Pharmacies.
    Blackburn DF; Evans CD; Eurich DT; Mansell KD; Jorgenson DJ; Taylor JG; Semchuk WM; Shevchuk YM; Remillard AJ; Tran DA; Champagne AP
    Pharmacotherapy; 2016 Oct; 36(10):1055-1064. PubMed ID: 27581815
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.